Related Experiment Video

Updated: May 10, 2026

Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports
07:44

Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports

Published on: November 28, 2019

Immunomodulation of the tumor microenvironment by Toll-like receptor-3 (TLR3) ligands

Valerie Chew1, Jean-Pierre Abastado

  • 1Singapore Immunology Network (SIgN); Agency for Science Technology and Research (ASTAR); 8A Biomedical Grove; Immunos; Biopolis, Singapore.

Oncoimmunology
|June 5, 2013
PubMed

Insights

Toll-like receptor-3 (TLR3) expression in hepatocellular carcinoma (HCC) predicts better survival. TLR3 ligands directly kill cancer cells, boost immune cell infiltration, and activate natural killer (NK) cells for improved outcomes.

Area of Science:

  • Immunology
  • Oncology
  • Molecular Biology

Background:

  • Intratumoral Toll-like receptor-3 (TLR3) expression is linked to improved survival in hepatocellular carcinoma (HCC) patients.
  • Understanding the mechanisms by which TLR3 influences HCC progression is crucial for developing novel therapies.

Purpose of the Study:

  • To elucidate the independent mechanisms through which Toll-like receptor-3 (TLR3) ligands exert anti-tumor effects in hepatocellular carcinoma (HCC).

Main Methods:

  • Analysis of intratumoral TLR3 expression in HCC patients.
  • In vitro and in vivo studies to assess the effects of TLR3 ligands on cancer cells and immune cells.
  • Evaluation of T-cell and natural killer (NK)-cell infiltration and activation.

Main Results:

  • TLR3 ligands demonstrate a direct cytotoxic effect on TLR3-expressing HCC cells.
  • TLR3 activation promotes the infiltration of T-cells and NK-cells into the tumor microenvironment.
  • TLR3 ligands enhance the activation of TLR3-expressing NK cells, augmenting anti-tumor immunity.

Conclusions:

  • TLR3 signaling offers a multifaceted therapeutic strategy against HCC.
  • Targeting TLR3 can simultaneously induce direct tumor cell killing and bolster anti-tumor immune responses.
  • These findings support the clinical investigation of TLR3 agonists for HCC treatment.
Keywords:
Toll-like receptorcancer vaccinechemokinehepatocellular carcinomaimmunotherapytumor microenvironment

More Related Videos

Tropomodulin 3 Overexpression as a Marker for Platinum Resistance and Immune Infiltration in Ovarian Cancer09:40

Tropomodulin 3 Overexpression as a Marker for Platinum Resistance and Immune Infiltration in Ovarian Cancer

Published on: August 2, 2024

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA (lncRNA)...